Trading / Browse Companies / Benchling Stock

Benchling Stock

benchling.comHealthcareFounded: 2012Funding to Date: $424.97MM

Benchling is a biotechnology company and developer of a platform that allows researchers to design and run experiments, analyze data, and share results.

Buy or sell Benchling stockLearn more about a potential Benchling IPO
Register for Details

For more details on financing and valuation for Benchling, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Benchling.

Register Today

Team

Management Team

Ashutosh Singhal
Co-Founder and Board Member
Kaiser Mulla-Feroze
Chief Marketing Officer
Sherwin Yu
Engineering Manager
Sajith Wickramasekara
Co-Founder, Chief Executive Officer and Board Member

Board Members

Eric Vishria
Sajith Wickramasekara
Balaji Srinivasan Ph.D
Andreessen Horowitz
Miles Grimshaw
Thrive Capital
Ashutosh Singhal

Other companies like Benchling in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.6B
NowRx
Sector
Healthcare
Last Round Est. Valuation
$334.19MM
Nutrafol
Sector
Healthcare
Last Round Est. Valuation
$150MM
Biosplice Therapeutics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Cytonics
Sector
Healthcare
 
 
Levels
Sector
Healthcare
Last Round Est. Valuation
$296.3MM
Cerebral
Sector
Healthcare
Last Round Est. Valuation
$4.8B

News

TechInsider 01/27/2021
$900 million cloud startup Benchling just launched a new product to help companies ramp up COVID research
Benchling, which is backed by investors Andreessen Horowitz and Thrive Capital, is helping customers scale coronavirus research and testing.
Crunchbase 06/01/2020
Benchling Brings In $50M Series D To Advance Biotech R&D
Benchling's cloud-based R&D platform helps scientists make breakthrough discoveries faster.
FINSMES 05/29/2020
Benchling Raises $50M in Series D Funding | FinSMEs
Benchling, a San Francisco, CA-based life sciences R&D cloud platform, closed $50m in Series D funding

Trending Companies

Frequently Asked Questions